PPA
ALXO icon

Parametric Portfolio Associates’s ALX Oncology ALXO Stock Holding History

Parametric Portfolio Associates’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-6,487
Closed -$479K – 3633
2021
Q3 		$479K Buy
6,487
+65
+1% +$4.33K ﹤0.01% 3125
2021
Q2 		$351K Buy
6,422
+1,363
+27% +$81.6K ﹤0.01% 3214
2021
Q1 		$373K Sell
5,059
-11,804
-70% -$929K ﹤0.01% 3621
2020
Q4 		$1.45M Buy
+16,863
New +$1.01M ﹤0.01% 2847

Other funds holding ALXO

VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Parametric Portfolio Associates's ALXO Position: Q4 2021 in Review

Parametric Portfolio Associates sold out of ALX Oncology (ALXO) in Q4 2021, closing a stake of 6,487 shares — an estimated $479K sold.

Parametric Portfolio Associates first reported a position in ALXO in Q4 2020 and held it in 4 quarters. The position peaked at $1.45M in Q4 2020. 108 funds tracked by Wall St. Rank hold ALXO as of Q4 2021.

  • Parametric Portfolio Associates reported no remaining ALX Oncology position as of Q4 2021 after selling out during the quarter.
  • Parametric Portfolio Associates sold 6,487 ALX Oncology shares in Q4 2021, an estimated $479K.
  • Parametric Portfolio Associates first reported a position in ALX Oncology in Q4 2020 and held it in 4 quarters.
  • Parametric Portfolio Associates's ALX Oncology position peaked at $1.45M in Q4 2020.
  • 108 funds tracked by Wall St. Rank held ALX Oncology as of Q4 2021.

Based on Parametric Portfolio Associates's 13F filing for Q4 2021, filed 15 Feb 2022.